Kalbe Farma Tbk PT
IDX:KLBF
Kalbe Farma Tbk PT
IDX:KLBF
Price:
1 390
IDR
4.51%
Market Closed
Market Cap:
65.2T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
KLBF Alert
Kalbe Farma Tbk PT
1390
+60 (+4.51%)
| 52 Week Range |
1 275
1 750
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Kalbe Farma Tbk PT
Balance Sheet
Balance Sheet Decomposition
Kalbe Farma Tbk PT
Kalbe Farma Tbk PT
| Current Assets | 17T |
| Cash & Short-Term Investments | 4.3T |
| Receivables | 5.2T |
| Other Current Assets | 7.5T |
| Non-Current Assets | 11.7T |
| Long-Term Investments | 455.8B |
| PP&E | 8.7T |
| Intangibles | 2.2T |
| Other Non-Current Assets | 393.1B |
| Current Liabilities | 4.1T |
| Accounts Payable | 1.9T |
| Accrued Liabilities | 782.7B |
| Short-Term Debt | 318.6B |
| Other Current Liabilities | 1.1T |
| Non-Current Liabilities | 2.5T |
| Long-Term Debt | 338.1B |
| Other Non-Current Liabilities | 2.1T |
Balance Sheet
Kalbe Farma Tbk PT
Kalbe Farma Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 894 610
|
2 718 619
|
2 895 582
|
2 784 706
|
3 153 328
|
3 040 487
|
5 207 929
|
6 216 248
|
3 949 769
|
3 232 421
|
|
| Cash |
386 300
|
652 296
|
604 556
|
848 354
|
785 338
|
980 905
|
2 324 854
|
2 892 558
|
1 634 557
|
1 319 710
|
|
| Cash Equivalents |
1 508 309
|
2 066 323
|
2 291 026
|
1 936 351
|
2 367 989
|
2 059 582
|
2 883 075
|
3 323 690
|
2 315 212
|
1 912 710
|
|
| Short-Term Investments |
199 390
|
155 754
|
179 326
|
186 495
|
178 719
|
195 619
|
188 316
|
258 923
|
145 307
|
165 496
|
|
| Total Receivables |
2 464 902
|
2 434 082
|
2 725 808
|
2 967 693
|
3 373 569
|
3 697 660
|
3 594 927
|
3 545 143
|
4 787 768
|
4 820 141
|
|
| Accounts Receivables |
2 346 944
|
2 354 780
|
2 631 206
|
2 876 417
|
3 255 545
|
3 572 855
|
3 477 221
|
3 431 018
|
4 613 623
|
4 651 971
|
|
| Other Receivables |
117 958
|
79 302
|
94 601
|
91 276
|
118 024
|
124 805
|
117 706
|
114 125
|
174 145
|
168 170
|
|
| Inventory |
3 090 544
|
3 003 150
|
3 344 404
|
3 557 497
|
3 474 587
|
3 737 976
|
3 599 746
|
5 087 300
|
7 027 358
|
6 791 980
|
|
| Other Current Assets |
471 360
|
436 888
|
427 410
|
547 560
|
468 085
|
550 749
|
484 414
|
604 596
|
800 028
|
907 687
|
|
| Total Current Assets |
8 120 805
|
8 748 492
|
9 572 530
|
10 043 951
|
10 648 288
|
11 222 491
|
13 075 332
|
15 712 210
|
16 710 230
|
15 917 724
|
|
| PP&E Net |
3 404 457
|
3 938 494
|
4 555 756
|
5 342 660
|
6 252 801
|
7 666 315
|
8 310 144
|
8 309 734
|
8 315 063
|
8 509 520
|
|
| PP&E Gross |
3 404 457
|
3 938 494
|
4 555 756
|
5 342 660
|
6 252 801
|
7 666 315
|
8 310 144
|
8 309 734
|
8 315 063
|
8 509 520
|
|
| Accumulated Depreciation |
1 874 810
|
2 160 877
|
2 459 135
|
2 815 468
|
3 155 030
|
3 519 373
|
3 995 050
|
4 458 296
|
5 209 438
|
5 747 917
|
|
| Intangible Assets |
128 428
|
122 000
|
106 927
|
126 293
|
140 161
|
369 273
|
464 792
|
936 075
|
1 044 149
|
1 304 706
|
|
| Goodwill |
293 280
|
293 280
|
293 280
|
293 280
|
293 280
|
293 280
|
195 226
|
209 684
|
479 347
|
479 347
|
|
| Note Receivable |
30 717
|
83 631
|
34 843
|
28 499
|
54 345
|
52 685
|
35 247
|
43 576
|
93 178
|
142 441
|
|
| Long-Term Investments |
40 834
|
57 650
|
89 132
|
78 862
|
86 106
|
91 064
|
123 338
|
303 272
|
384 543
|
450 799
|
|
| Other Long-Term Assets |
420 746
|
452 870
|
573 543
|
702 696
|
671 224
|
569 619
|
360 221
|
152 086
|
214 802
|
253 031
|
|
| Other Assets |
293 280
|
293 280
|
293 280
|
293 280
|
293 280
|
293 280
|
195 226
|
209 684
|
479 347
|
479 347
|
|
| Total Assets |
12 439 267
N/A
|
13 696 417
+10%
|
15 226 009
+11%
|
16 616 239
+9%
|
18 146 206
+9%
|
20 264 727
+12%
|
22 564 300
+11%
|
25 666 635
+14%
|
27 241 313
+6%
|
27 057 568
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 133 093
|
1 068 666
|
1 127 307
|
1 108 551
|
1 289 898
|
1 215 860
|
1 240 386
|
1 667 596
|
1 996 615
|
1 690 720
|
|
| Accrued Liabilities |
393 588
|
440 670
|
408 980
|
322 031
|
301 100
|
469 464
|
481 949
|
710 937
|
601 327
|
478 541
|
|
| Short-Term Debt |
251 909
|
266 148
|
147 394
|
168 775
|
69 155
|
149 638
|
220 500
|
0
|
705 600
|
120 800
|
|
| Current Portion of Long-Term Debt |
0
|
1 829
|
1 298
|
4 614
|
28 251
|
19 519
|
148 764
|
93 646
|
150 219
|
179 683
|
|
| Other Current Liabilities |
607 330
|
588 568
|
632 181
|
623 365
|
597 764
|
722 627
|
1 085 128
|
1 062 478
|
977 278
|
773 425
|
|
| Total Current Liabilities |
2 385 920
|
2 365 880
|
2 317 162
|
2 227 336
|
2 286 167
|
2 577 109
|
3 176 726
|
3 534 656
|
4 431 038
|
3 243 169
|
|
| Long-Term Debt |
44 220
|
130 933
|
134 417
|
145 603
|
260 002
|
647 688
|
788 552
|
532 509
|
311 899
|
321 144
|
|
| Deferred Income Tax |
11 300
|
6 602
|
582
|
637
|
129
|
242
|
2 591
|
19 572
|
32 500
|
35 790
|
|
| Minority Interest |
434 022
|
473 163
|
554 582
|
613 224
|
671 137
|
812 456
|
870 549
|
1 686 352
|
1 712 110
|
1 701 166
|
|
| Other Liabilities |
233 726
|
254 716
|
310 002
|
348 632
|
305 313
|
334 106
|
320 350
|
314 019
|
368 547
|
337 443
|
|
| Total Liabilities |
3 109 188
N/A
|
3 231 294
+4%
|
3 316 745
+3%
|
3 335 432
+1%
|
3 522 748
+6%
|
4 371 600
+24%
|
5 158 767
+18%
|
6 087 109
+18%
|
6 856 095
+13%
|
5 638 712
-18%
|
|
| Equity | |||||||||||
| Common Stock |
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
468 751
|
|
| Retained Earnings |
8 892 788
|
10 006 398
|
11 415 505
|
12 787 858
|
14 073 109
|
15 361 121
|
16 875 671
|
19 123 573
|
20 874 948
|
21 883 981
|
|
| Additional Paid In Capital |
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
34 119
|
|
| Unrealized Security Profit/Loss |
9 459
|
4 726
|
32 826
|
36 878
|
42 056
|
56 006
|
39 111
|
73 994
|
101 896
|
98 337
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
2 063
|
2 063
|
1 003 973
|
1 003 973
|
|
| Other Equity |
6 801
|
19 367
|
26 302
|
21 438
|
73 660
|
41 367
|
58 182
|
50 610
|
22 285
|
5 879
|
|
| Total Equity |
9 330 079
N/A
|
10 465 123
+12%
|
11 909 265
+14%
|
13 280 807
+12%
|
14 623 458
+10%
|
15 893 126
+9%
|
17 405 533
+10%
|
19 579 526
+12%
|
20 385 218
+4%
|
21 418 857
+5%
|
|
| Total Liabilities & Equity |
12 439 267
N/A
|
13 696 417
+10%
|
15 226 009
+11%
|
16 616 239
+9%
|
18 146 206
+9%
|
20 264 727
+12%
|
22 564 300
+11%
|
25 666 635
+14%
|
27 241 313
+6%
|
27 057 568
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
46 875
|
46 875
|
46 875
|
46 875
|
46 875
|
46 875
|
46 873
|
46 873
|
46 256
|
46 256
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
